Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
CANCER:
Maxillary Sinus Carcinoma
Associations
(6)
News
Trials
A2 | Sensitive
A2 | Resistant
Show legend
Group by Gene:
Drug categories
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
EGFR
Tyrosine Kinase Inhibitors
Cancel
PD1 inhibitor
pembrolizumab
PD1 inhibitor, EGFR inhibitor
pembrolizumab + cetuximab
VC
Chemotherapy
EP
CAV
No biomarker
A2
No biomarker
|
Maxillary Sinus Carcinoma
|
pembrolizumab
A2
No biomarker
|
Maxillary Sinus Carcinoma
|
pembrolizumab + cetuximab
A2
No biomarker
|
Maxillary Sinus Carcinoma
|
VC
A2
No biomarker
|
Maxillary Sinus Carcinoma
|
EP
A2
No biomarker
|
Maxillary Sinus Carcinoma
|
CAV
MSI-H/dMMR
A2
MSI-H/dMMR
|
Maxillary Sinus Carcinoma
|
pembrolizumab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
